These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 22971278

  • 1. [The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology].
    Jiang YF, Ma J, He B, Li NP, Tang W, Gong GZ.
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):344-7. PubMed ID: 22971278
    [Abstract] [Full Text] [Related]

  • 2. [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].
    Yang Q, Gong ZJ, Hu DF.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):515-9. PubMed ID: 19912686
    [Abstract] [Full Text] [Related]

  • 3. [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].
    Yang Q, Gong ZJ, Hu DF.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):821-4. PubMed ID: 18073064
    [Abstract] [Full Text] [Related]

  • 4. [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
    Xing J, Han T, Liu L, Li Y, Li J, Li Y, Xiao SX.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):828-32. PubMed ID: 22433304
    [Abstract] [Full Text] [Related]

  • 5. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N, Zhou Z, Zhang DZ, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266
    [Abstract] [Full Text] [Related]

  • 6. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
    Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F, Club Epatologi Ospedalieri (CLEO) Group.
    Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
    Duan SH, Bao ZY, Yuan XD, Wang L, Liu MS.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):535-8. PubMed ID: 27386642
    [Abstract] [Full Text] [Related]

  • 8. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.
    Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL, Adefovir Dipivoxil 438 Study Group.
    Gastroenterology; 2006 Dec; 131(6):1743-51. PubMed ID: 17087951
    [Abstract] [Full Text] [Related]

  • 9. [The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].
    Xie DY, Lin BL, Xu QH, Chen YM, Lu WL, Li JG, Gao ZL.
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):341-4. PubMed ID: 18510844
    [Abstract] [Full Text] [Related]

  • 10. [A clinical study of adefovir dipivoxil, made in China, for treatment of hepatitis B e antigen-positive patients with chronic hepatitis B].
    Lin XH, Si CW, Yu YY, Li J, Chen XY, Ren XM, Liu P, Zhang SL, Kang XP.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):898-901. PubMed ID: 17196132
    [Abstract] [Full Text] [Related]

  • 11. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
    Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL, Adefovir Dipivoxil 437 Study Group.
    N Engl J Med; 2003 Feb 27; 348(9):808-16. PubMed ID: 12606735
    [Abstract] [Full Text] [Related]

  • 12. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.
    Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E.
    Hepatology; 2008 Jun 27; 47(6):1863-71. PubMed ID: 18433023
    [Abstract] [Full Text] [Related]

  • 13. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
    Chen LY, Zhu LY, Yang BS, Bi MR, Yan BZ, Wang W, Ma YJ.
    Hepatogastroenterology; 2012 Jun 27; 59(120):2582-6. PubMed ID: 22626879
    [Abstract] [Full Text] [Related]

  • 14. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
    Vassiliadis TG, Giouleme O, Koumerkeridis G, Koumaras H, Tziomalos K, Patsiaoura K, Grammatikos N, Mpoumponaris A, Gkisakis D, Theodoropoulos K, Panderi A, Katsinelos P, Eugenidis N.
    J Gastroenterol Hepatol; 2010 Jan 27; 25(1):54-60. PubMed ID: 19780875
    [Abstract] [Full Text] [Related]

  • 15. [The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].
    Moon JH, Cho M, Yoon KT, Bae JH, Heo J, Kim GH, Kang DH, Song GA.
    Korean J Hepatol; 2008 Dec 27; 14(4):503-12. PubMed ID: 19119245
    [Abstract] [Full Text] [Related]

  • 16. A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B.
    Zeng M, Mao Y, Yao G, Wang H, Hou J, Wang Y, Ji BN, Chang CN, Barker KF.
    Hepatology; 2006 Jul 27; 44(1):108-16. PubMed ID: 16799983
    [Abstract] [Full Text] [Related]

  • 17. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
    Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL, Adefovir Dipivoxil 438 Study Group.
    N Engl J Med; 2003 Feb 27; 348(9):800-7. PubMed ID: 12606734
    [Abstract] [Full Text] [Related]

  • 18. [Experimental study on effect of dahuang zhechong wan combined with adefovir dipivoxil in preventing hepatic fibrosis in patients with chronic hepatitis B].
    Zhang L, Chang Y.
    Zhongguo Zhong Yao Za Zhi; 2012 Mar 27; 37(6):862-4. PubMed ID: 22715739
    [Abstract] [Full Text] [Related]

  • 19. Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.
    Chu M, Cho SM, Choe BH, Cho MH, Kwon S, Lee WK.
    J Pediatr Gastroenterol Nutr; 2012 Dec 27; 55(6):648-52. PubMed ID: 22688509
    [Abstract] [Full Text] [Related]

  • 20. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F.
    N Engl J Med; 2008 Dec 04; 359(23):2442-55. PubMed ID: 19052126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.